Tag: cfDNA
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
By Kara Nyberg, PhD
Posted: June 24, 2020
An exploratory analysis of circulating free DNA (cfDNA) shows that lorlatinib confers potent antitumor activity in pretreated patients...
Experts Discuss Turnaround Times, Geographic Differences Regarding Liquid Biopsy
Improved Turnaround Times for Biopsy Results Matters More Than Type of Biopsy
By Dr. Edgardo S. Santos Castillero, MD, FACP
Posted: December 11, 2019
Regarding “Liquid Biopsy for Assessing...
